USP22 promotes angiotensin II-induced podocyte injury by deubiquitinating and stabilizing HMGB1
Authors:
- 28 March 2025
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 131, 111771
Abstract
No abstract availableKeywords
Funding Information
- Hubei Province Natural Science Foundation (2023AFB702)
- National Natural Science Foundation of China (82100704, 82070713, 82170715)
This publication has 42 references indexed in Scilit:
- Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver diseaseMetabolism, 2023
- Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis progression and resolution in miceJournal of Hepatology, 2023
- USP7 - a crucial regulator of cancer hallmarksBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1European Journal of Pharmacology, 2023
- Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacementKidney International, 2023
- Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress responseJournal of Biological Chemistry, 2021
- Location is the key to function: HMGB1 in sepsis and trauma-induced inflammationJournal of Leukocyte Biology, 2019
- Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016Kidney International, 2018
- Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologiesBiomedicine & Pharmacotherapy, 2017
- Podocyte injury and its consequencesKidney International, 2016